LS-102 treatment elevated the levels of apoptosis as indicated by increased cleaved caspase-3 and Bax levels, along with decreased Bcl-2 levels, compared to both control and PCOS groups (Figure 6(e)). This evidence concerns the gene CASP3 and polycystic ovary syndrome.